
Background and Statement of Need
The Diversa Corporation is considered as a global leader in the development and application of proprietary technologies committed to discovering and evolving novel genes and gene pathways for all types of sources. The company uses a fully integrated approach to developing novel enzymes and other biologically active compounds such as orally active drugs that are produced by these genes and pathways (Diversa 2003). Their evolved technologies help the optimization of genes that enable product solutions for multiple markets such as the pharmaceutical, agricultural, chemical processing, and industrial.